Engineering the Treatment of Early-Stage Lung Cancer [SPONSORED]
Early-stage lung cancers are not only difficult to diagnose—they’ve also proved difficult to curatively treat.
Early-stage lung cancers are not only difficult to diagnose—they’ve also proved difficult to curatively treat.
Thousands of tumor samples provide the clearest link yet between cancer and fungi, but more research is needed
U.S. lung cancer screening guidelines miss people who have never smoked, as well as many women and Black people. Expanding outreach and eligibility could help
Data show that smoking, drinking alcohol and having a high body mass index are the biggest contributors to cancer worldwide
Recognizing those who are making a meaningful impact in the lives of cancer patients, the Cancer Community Awards, sponsored by AstraZeneca, presents an individual or organization with the President’s Award...
Celebrating those who enhance the ability to provide the right treatment for the right patient at the right time, the Cancer Community Awards, sponsored by AstraZeneca, presents an individual or organization with the Catalyst for Precision Medicine Award...
Celebrating those who significantly improve access to cancer care for underserved populations, the Cancer Community Awards, sponsored by AstraZeneca, presents an individual or organization with a Catalyst for Change Award...
Celebrating those who strive to overcome disparities in cancer care to bring quality services to their patients, the Cancer Community Awards, sponsored by AstraZeneca, created the Catalyst for Equity Award. We spoke with Dr...
Celebrating those who are making a patient’s experience as easy as possible during an extraordinarily difficult time, the Cancer Community Awards, sponsored by AstraZeneca, presents an individual or organization with a Catalyst for Care Award...
Protons, muons, neutrinos and other particles are moving beyond the realm of physics to help in a myriad of ways
This leading cancer affects some populations and regions much more than others
Older patients are underrepresented in clinical trial research. Here’s how we can change that
A new study offers a possible answer to the question “Why me?”
Partnerships with top research centers, along with advanced technology, may help local doctors offer patients the latest therapies
Elizabeth Stern’s research led the way to our modern understanding of the prevention, treatment and diagnosis of cervical cancer
An archival project aims to document the experiences of people who suffered from U.S. nuclear weapons testing
People with diseases or treatments that suppress their immune system cannot count on the same protection most vaccinated people have
The organization’s underfunding means critical research is not being done
Colorectal cancer rates in younger adults are climbing. The race is on to figure out why
Oncologists are grappling with predicting—and mitigating—the effects of the pandemic
Support science journalism.
Thanks for reading Scientific American. Knowledge awaits.
Already a subscriber? Sign in.
Thanks for reading Scientific American. Create your free account or Sign in to continue.
Create Account